| 20.57 Delayed Data As of Nov 20 |  -1.65 / -7.43%Today’s Change | 12.55 Today|||52-Week Range 23.38 | +40.89% Year-to-Date |
| Horizon Pharma (HZNP) Q3 Earnings & Sales Beat, Shares Rise Nov 08 / Zacks.com - Paid Partner Content | Horizon Pharma (HZNP) Tops Q3 Earnings and Revenue Estimates Nov 07 / Zacks.com - Paid Partner Content |
| Previous close | 22.22 |
| Today’s open | 22.02 |
| Day’s range | 20.55 - 22.19 |
| Volume | 1,581,516 |
| Average volume (3 months) | 1,552,640 |
| Market cap | $3.7B |
| Earnings growth (last year) | -142.31% |
| Earnings growth (this year) | +43.59% |
| Earnings growth (next 5 years) | +14.90% |
| Revenue growth (last year) | +0.97% |
| P/E ratio | NM |
| Price/Sales | 2.25 |
| Price/Book | 3.69 |
| Today’s change | Today’s % change | |
|---|---|---|
| GWPHGW Pharmaceuticals P... | -4.18 | -3.33% |
| AGIOAgios Pharmaceutical... | -0.68 | -1.02% |
| EBSEmergent BioSolution... | +0.04 | +0.06% |
| TAROTaro Pharmaceutical ... | -0.92 | -0.92% |
| Next reporting date | March 4, 2019 |
| EPS forecast (this quarter) | $0.55 |
| Annual revenue (last year) | $1.1B |
| Annual profit (last year) | -$410.5M |
| Net profit margin | -38.87% |
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chairman, President & Chief Executive Officer Timothy P. Walbert |
Senior VP-Business Operations & Government Affairs Robert W. Metz |
Corporate headquarters Dublin, Dublin |
